Mursla, a liquid biopsy company, has raised £410K from the UK Government’s Future Fund and existing investors. In addition, the organisation has secured a £40K COVID-19 grant from the Cambridgeshire Capital Grant Scheme. The funding will enable Mursla to finalise ...
Read More »ArunA Bio Raises $5.3 Million to fuel growth and innovation for its neural exosome therapeutic platform
ArunA Bio today announced that it has secured $5.3 million to further the development of its neural exosome therapeutic platform and manufacturing processes for a broad range of neurological disorders. The funding was raised from existing angel investors. ArunA’s neural ...
Read More »OncoDNA raises EUR 7.7 million in equity to fund growth
OncoDNA announced the closing of a new equity round with EUR 7.7 million. This financing was subscribed by the historical shareholders and a new group of investors, led by Ackermans & van Haaren. The funds will be used by OncoDNA ...
Read More »National Science Challenge seed funding to explore use of exosomes for early cancer detection
Victoria University of Wellington researchers have received $255,000 in seed funding to develop new magnetic resonance imaging (MRI) contrast agents for early detection of cancer and other diseases. Dr Renee Goreham, a postdoctoral fellow in Victoria’s School of Chemical and ...
Read More »NIH Seeks Grant Applications on Cancer Exosome Biomarker Research
from GenomeWeb – The National Institutes of Health announced that it is seeking grant applications for projects investigating the potential of exosomes and extracellular vesicles (EVs), as well as their cargo, as biomarkers for cancer risk assessment, detection, diagnosis, and ...
Read More »